• PRESENTATIONS

• PUBLICATIONS

Listen to Lectures by Dr. Ballantyne on WebSurg The Largest Collection of Educational Material on Laparoscopic Surgery

RECENT BARIATRIC SURGERY PRESENTATIONS

Schmidt H, Weber P, Merola S, Ballantyne GH. Laparoscopic gastric bypass. Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Storz Endoscopy Booth; St. Louis, Missouri, April 20^th, 2001

Weber P, Merola S, Wasielewski A, Fan P, Davies R, Ballantyne GH, Schmidt H. Laparoscopic Gastric Bypass in Super-Obese Patients. 9^th International Congress of the International Association of European Endoscopic Surgeons. Maastricht, Netherland. June 13-16, 2001.

Oliak D,  Schmidt H, Weber P,  Wasielewski A,  Fan P, Ballantyne GH.. The learning curve for laparoscopic roux-en-Y gastric bypass. 8th World Congress, SAGES (Society of Gastrointestinal Endoscopic Surgeons), New York, New York, March n16th, 2002.

Oliak D, Schmidt H, Fan P, Ballantyne GH. Is laparoscopic gastric bypass safe for patients with BMI greater than 60? American Society for Bariatric Surgeons. 2002.

Oliak D, Schmidt H, Wasielewski A, Ballantyne GH. Laparoscopic gastric bypass in a patient with a BMI of 75. EAES (European Association of Endoscopic Surgerons), Lisbon, Portugal, June 4th, 2002. (video presentation).

Oliak D, Schmidt H, Wasielewski A, Davies RJ, Ballantyne GH. Laparoscopic gastric bypass for older patients.  SLS (Society of Laparoendoscopic Surgeons), New Orleans, September, 2002

Svahn J, Schmidt H, Haag B, Trivedi A, Wasielewski A, BALLANTYNE GH. Transabdominal access for ERCP following laparoscopic gastric bypass. European Association of Endoscopic Surgeons. Glosgow, United Kingdom. June 18^th, 2003.

BALLANTYNE GH. Outcomes for laparoscopic gastric bypass. Peruvian Society of Surgeons. Lima, Peru. November 21, 2003.

BALLANTYNE GH. Predictors of Hospital Length of Stay Following Open and Laparoscopic Gastric Bypass for Morbid Obesity. Surgical Biology Club III. American College of Surgeons. Chicago, Illinois. October 19^th, 2003.

Ewing DR, Capella RF, Capella JF, Davis D, Schmidt J, Wasielewski A, BALLANTYNE GH. Factors that impact operative times for laparoscopic and open gastric bypass. Society of Gastrointestinal Endoscopic Surgeons (SAGES). Denver, Colorado. April 1, 2004. (Poster).

Chau Y, BALLANTYNE GH, Trivedi A, Wasielewski A, BALLANTYNE GH, Schmidt J. Factors that impact weight loss following laparoscopic adjustable gastric banding. The American Society of Bariatric Surgery (ASBS). San Diego, CA. June, 2004.

BALLANTYNE GH. Achieving excellent long term outcomes following bariatric surgery. 2^nd National Conference on Adding, Updating and Expanding Bariatric Surgery Service. Washington, D.C. July 24^th, 2004.

O’Brien P, Nyugen M, BALLANTYNE GH. Laparoscopic gastric bypass or laparoscopic adjustable gastric banding for morbid obesity. American College of Surgeons. Apllied Medical Booth. New Orleans, LA. October 12^th, 2004.

Iannace VA; Capella RF, BALLANTYNE GH, Capella JF. Tubular Banded Gastric Bypass for the Treatment of Extreme Obesity (Triple Obesity). The American Society of Bariatric Surgery, Orlando, FL, June 2005. (Poster).

Iannace VA, Capella RF, BALLANTYNE GH, Capella JF, MD Erosions and Migrations of Restrictive Bands Following Bariatric Surgery. The American Society of Bariatric Surgery, Orlando, FL, June 2005. (Poster)

Laker S, Farkas D, Iannace V, Wasielewski A, Schmidt H, Trivedi A, BALLANTYNE GH Laparoscopic Roux-En-Y Gastric Bypass (LRYGB) Resolves Insulin Resistance (IR): Incretin or Adipocytokine Action? The Society for American Gastrointestinal Endoscopic Surgeons (SAGES), Hollywood, FL, April, 2005

Farkas D, Laker S, Iannace V, Wasielewski A, Schmidt H, Trivedi A, BALLANTYNE GH. How Much of the Weight Loss After Laparoscopic Gastric Bypass is Fat? The Society for American Gastrointestinal Endoscopic Surgeons (SAGES),Hollywood, FL, April, 2005.

Farkas D, Laker S, Iannace V, Wasielewski A, Schmidt H, Trivedi A, BALLANTYNE GH. Patients 12 Months After Laparoscopic Gastric Bypass have Body Compositions Similar to Controls. The Society for American Gastrointestinal Endoscopic Surgeons ( SAGES), Hollywood, FL, April, 2005.

Farkas D, Laker S, Iannace V, Wasielewski A, BALLANTYNE GH. Insulin Resistance Improves Within Three Months After Both Laparoscopic Gastric Bypass and Lap-Band. The European Association of Endoscopic Surgeons (EAES), Venice, Italy, June, 2005.

BALLANTYNE GH. Gut Hormones & Appetite. Advanced Course in Morbid Obesity Surgery. The European Institute of Tele-Surgery. IRCAD-EITS. University of Strasbourg. Strasbourg, Alsace, France. October 1^st, 2005.

 BALLANTYNE GH. The Future of Bariatric Surgery. Advanced Course in Morbid Obesity Surgery. The European Institute of Tele-Surgery. IRCAD-EITS. University of Strasbourg. Strasbourg, Alsace, France. October 1^st, 2005.

Chemounay J, Belsley SF, Cordova AC, Wasielewski A, BALLANTYNE GH. Does age impact % Excess Weight Loss (% EWL) after Laparoscopic Rouxe-en-Y Gastric Bypass (LRYGB)? Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Dallas, Texas. April 27^th, 2006 (Poster).

Falloon M, Belsley SJ, Farkas D, Wasielewski A, BALLANTYNE GH. Does C Reactive Protein (CRP) decrease proportionately with body mass index (BMI) after both Lap Band & LRYGB? Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Dallas, Texas. April 27^th, 2006 (Poster).

BALLANTYNE GH. The Future of Bariatric Surgery. Advanced Course in Morbid Obesity Surgery. The European Institute of Tele-Surgery. IRCAD-EITS. University of Strasbourg. Strasbourg, Alsace, France. June 1^st, 2006.

BALLANTYNE GH. Introduction to neuroendocrine bariatric surgery. Metabolic Symposium for Morbid Obesity. International Federation for the Study of Obesity (IFSO). Sydney, Australia. August 29^th, 2006.

BALLANTYNE GH. Metabolic impact after bariatric surgery in patients with Type 2 Diabetes Mellitus. At: Incretins: New Visions for Old Hormones. Brazilian Diabetes Society & the Brazilian Association for the Study of Obesity. University of Campinas, Sao Paulo, Brazil. November 18^th, 2006.

BALLANTYNE GH. Neuroendocrine response to metabolic surgery. The 1^st Workshop on Metabolic Surgery for Morbid Obesity and Diabetes. Yokohama, Japan. March 10^th, 2007.

BALLANTYNE GH. Voting member. International Conference: Gastrointestinal Surgery to Treat Type 2 Diabetes. Clinical and Research Guidelines Development. Rome, Italy. March 29-31, 2007.

Belsley SJ, Athinos J, Stephens DJ, Saunders JK, Schmidt H, Trivedi A, Ewing D, Capella R, Iannace V, Davis D, Wasielewski A, Moran S, Ballantyne GH. Hospital costs differ for elective bariatric surgical procedures performed in patients 60 years old. Society of American Gastrointestinal Endoscopic Surgeons (SAGES), Las Vegas, Nevada. April 22, 2007.

Stephens DJ, Saunders JK, Schmidt H, Trivedi A, Ewing D, Capella R, Iannace V, Davis D, Wasielewski A, Moran S, BALLANTYNE GH. Short term outcomes following bariatric surgery in super-super obese (BMI > 60 kg/m²) patients. Society of American Gastrointestinal Endoscopic Surgeons (SAGES), Las Vegas, Nevada. April 22, 2007.

BALLANTYNE GH. Introduction to neuroendocrine bariatric surgery. Metabolic Surgery: Fact or Fiction? International Federation for the Surgery of Obesity (IFSO) Latin American Chapter. Cancun, Mexico. April 28^th, 2007.

BALLANTYNE GH, Belsley S.  Obesity surgery in the elderly & the impact of bariatric surgery on Type 2 Diabetes Mellitus.. Surgical Week. Belgian Society of Surgery. Ostend, Belgium. May 2^nd, 2007.

BALLANTYNE GH. Introduction to neuroendocrine bariatric surgery. Metabolic Surgery Today. American Society of Bariatric Surgery. Tijuana, Mexico. June 12^th, 2007.

BALLANTYNE GH. Hormonal Changes after Bariatric Surgery. IX Congress of the Sociedade Brasileira de Chirurgia Bariatrica e Metabolica (SBCBM). Curitiba, State of Parana, Brazil. December 11^th, 2007.

BALLANTYNE GH. Surgical treatment of Type II Diabetes Mellitus with Laparoscopic Adjustable Gastric Banding (LAGB) and laparoscopic Roux-en-Y Gastric Bypass (LRYGB). 53rd Annual Congress, Chilean Chapter of the American College of Surgeons, Santiago, Chile. May 4^th, 2009.

BALLANTYNE GH. Gut hormone changes following Laparoscopic Adjustable Gastric Banding (LAGB) and Laparoscopic Roux-en-Y gastric Bypass (LRYGB). 53rd Annual Congress, Chilean Chapter of the American College of Surgeons, Santiago, Chile. May 4^th, 2009.

BALLANTYNE GH. Low Moratlity at a High Volume bariatric Surgery Center. 53rd Annual Congress, Chilean Chapter of the American College of Surgeons, Santiago, Chile. May 5^th, 2009.

RECENT BARIATRIC SURGERY PUBLICATIONS

LEARN MORE ABOUT Dr. BALLANTYNE, HIS PROFESSIONAL STAFF,
HOW HE EVALUATES PATIENTS & WEIGHT LOSS SURGERY

SURGICAL SOCIETIES & NATIONAL INSTITUTE OF HEALTH
GUIDELINES & STATEMENTS
ON WEIGHT LOSS SURGERY

GARTH H. BALLANTYNE, M.D., M.B.A.
F.A.C.S., F.A.S.C.R.S.
SURGEON IN CHIEF

BOARD CERTIFIED IN:
GENERAL SURGERY & COLON AND RECTAL SURGERY

OFFICE: 
4 SHAW'S COVE
SUITE #201
NEW LONDON, CT 06320

CURRENT POSITIONS
SURGEON IN CHIEF
LAWRENCE & MEMORIAL HOSPITAL
NEW LONDON, CT 06320

PRACTICE LIMITED TO LAPAROSCOPIC SURGERY

CONTACT US AT:
1-860-444-7675

This page last updated: September 10, 2010 07:53 PM